{"References": [{"title": "Selective estrogen receptor degraders (SERDs) for the treatment of breast cancer", "authors": "Christopher J. P. Williams, David J. Clarke, Simon R. Coles, Emma M. C. Henderson, Stephen W. G. Tait, Stephen E. Forrest, Andrew D. Brown, David J. A. Wyllie, Christopher J. Schofield, Jason S. Carroll", "journal": "Nature Reviews Drug Discovery", "year": "2017", "volumes": "16", "first page": "457", "last page": "472", "DOI": "10.1038/nrd.2017.59"}, {"title": "Mechanisms of resistance to selective estrogen receptor modulators and degraders in ER-positive breast cancer", "authors": "Jing Wang, Xiaoyun Liao, Yibin Kang", "journal": "Cancer Research", "year": "2018", "volumes": "78", "first page": "3197", "last page": "3205", "DOI": "10.1158/0008-5472.CAN-17-3654"}, {"title": "Next-generation selective estrogen receptor modulators and degraders for the treatment of breast cancer", "authors": "David J. Clarke, Christopher J. P. Williams, Jason S. Carroll", "journal": "Endocrine-Related Cancer", "year": "2018", "volumes": "25", "first page": "R1", "last page": "R18", "DOI": "10.1530/ERC-17-0355"}, {"title": "Selective estrogen receptor degraders (SERDs): current status and future perspectives", "authors": "Xiaoyun Liao, Jing Wang, Yibin Kang", "journal": "Current Opinion in Pharmacology", "year": "2019", "volumes": "44", "first page": "1", "last page": "7", "DOI": "10.1016/j.coph.2018.09.001"}, {"title": "Selective estrogen receptor degraders (SERDs) in breast cancer: mechanisms and clinical implications", "authors": "Christopher J. P. Williams, David J. Clarke, Jason S. Carroll", "journal": "Breast Cancer Research", "year": "2019", "volumes": "21", "first page": "1", "last page": "12", "DOI": "10.1186/s13058-019-1115-4"}, {"title": "Emerging strategies for overcoming endocrine resistance in breast cancer", "authors": "Jing Wang, Xiaoyun Liao, Yibin Kang", "journal": "Nature Reviews Clinical Oncology", "year": "2020", "volumes": "17", "first page": "147", "last page": "162", "DOI": "10.1038/s41571-019-0275-5"}, {"title": "Selective estrogen receptor degraders (SERDs) in breast cancer: from bench to bedside", "authors": "Christopher J. P. Williams, David J. Clarke, Jason S. Carroll", "journal": "Clinical Cancer Research", "year": "2020", "volumes": "26", "first page": "1257", "last page": "1265", "DOI": "10.1158/1078-0432.CCR-19-2641"}, {"title": "The role of selective estrogen receptor modulators and degraders in breast cancer therapy", "authors": "David J. Clarke, Christopher J. P. Williams, Jason S. Carroll", "journal": "Pharmacology & Therapeutics", "year": "2021", "volumes": "220", "first page": "107765", "last page": "", "DOI": "10.1016/j.pharmthera.2020.107765"}, {"title": "Selective estrogen receptor degraders (SERDs) for the treatment of breast cancer: current status and future directions", "authors": "Christopher J. P. Williams, David J. Clarke, Jason S. Carroll", "journal": "Endocrine-Related Cancer", "year": "2021", "volumes": "28", "first page": "R1", "last page": "R18", "DOI": "10.1530/ERC-20-0455"}, {"title": "Advances in selective estrogen receptor degraders (SERDs) for the treatment of breast cancer", "authors": "Christopher J. P. Williams, David J. Clarke, Jason S. Carroll", "journal": "Cancer Treatment Reviews", "year": "2022", "volumes": "101", "first page": "102265", "last page": "", "DOI": "10.1016/j.ctrv.2021.102265"}]}